ScleroSafe™
VVT Medical’s Universal Platform for the treatment of all Chronic Venous Insufficiency (CVI) conditions via non-thermal, non-tumescent endovenous chemical ablation (ECA or Sclerotherapy). ScleroSafe’s regulatory pathway: FDA 510(k), CE, CDSCO (India), ANVISA (Brazil), TGA (Australia), Amar (Israel), and a Medical Device classification in the Emirates.
Indications
ScleroSafe is designed to treat shallow varicosities and visible veins in the legs, including truncal, reticular and sub dermal congested veins. Indicated for: ablation of veins with a diameter of 2 to 5mm (in Europe), and 2 to 3mm (in the U.S).
Configurations
ScleroSafe can be used with the 5cc\10cc Dual Syringe, a proprietary, specially designed 5F 150mm long or 5F 350mm long double lumen catheter and a dedicated guide wire.
Dimensions
5F/ 150mm 5F/ 350mm
Inverse Action, Dual Syringe
VVT’s unique, inverse action dual syringe (also known as the DPS) injects the ECA substance into the vein through one syringe while simultaneously aspirating blood through the second syringe – all within a single motion and with single-hand operation.
The aspiration of the blood results in negative pressure just behind the injected sclerosant agent. This key feature prevents uncontrolled overspill of the sclerosant upstream, ensures that there is no dilution of sclerosant with blood and minimizes the risk of inflammation. There is minimal pain, no scarring, discoloration or matting, no trapped blood clots, minimal to zero thrombophlebitis and immediate, visible results. VVT’s unique syringe is compatible with both foam and liquid ECA substances.
Double Lumen Catheter
ScleroSafe products feature a range of double lumen catheters with options for different lengths, gauges, levels of stiffness and other mechanical properties to optimize treatment- both at the site and within the blood vessel. All ScleroSafe catheters use a monorail guidewire system and are designed to simultaneously inject the ECA substance from the distal end, while aspirating the blood both in front of and behind the injected substance. They also share the universal compatibility feature of the Inverse Action, Dual Syringe module.
The patient's smile at the end of the pain-free treatment is the best compensation for my efforts. ScleroSafe™ gives patients and doctors a new sense of therapy. It is the next generation of varicose vein treatment: safe, convenient and effective. I would recommend all doctors to use this procedure.
The patient's smile at the end of the pain-free treatment is the best compensation for my efforts. ScleroSafe™ gives patients and doctors a new sense of therapy. It is the next generation of varicose vein treatment: safe, convenient and effective. I would recommend all doctors to use this procedure.
Patient Testimonial
S. is 34 years old. She has a family history of Varicose Veins. In an ultrasound exam at the age of 19, she unintentionally discovered she had varicose veins.
The doctor recommended her to treat them after pregnancy. This interview was taken 5 min. after going through a ScleroSafe procedure.
Meet our Groundbreaking Solutions
Please fill in the following details and one of our skilled professionals will get back to you
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.